Search research articles
Contact Us
Filters
Showing results (891-900 of 932) with videos related to
Page
of 94
Sort By:
Clinical Genitourinary Cancer
|
September 6, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2023
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
European Urology
|
August 15, 2024
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study
Talal El Zarif, Karl Semaan, Wanling Xie, et al.
The Prostate
|
May 6, 2025
Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant
A Mandl, M L Zahurak, N A Metri, et al.
The Journal of Clinical Investigation
|
November 1, 2022
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
Shuang G Zhao, Jamie M Sperger, Jennifer L Schehr, et al.
JAMA Network Open
|
November 12, 2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, et al.
Cancer Discovery
|
April 1, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
Marina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Cancer Discovery
|
February 6, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes
Marina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
BJU International
|
October 1, 2021
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer
Dimitrios Makrakis, Rafee Talukder, Leonidas N Diamantopoulos, et al.
Page
of 94
Search research articles
Search
Showing results (891-900 of 932) with videos related to
Sort By:
Page
of 94
Clinical Genitourinary Cancer
|
September 6, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 19, 2023
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
European Urology
|
August 15, 2024
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study
Talal El Zarif, Karl Semaan, Wanling Xie, et al.
The Prostate
|
May 6, 2025
Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant
A Mandl, M L Zahurak, N A Metri, et al.
The Journal of Clinical Investigation
|
November 1, 2022
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
Shuang G Zhao, Jamie M Sperger, Jennifer L Schehr, et al.
JAMA Network Open
|
November 12, 2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, et al.
Cancer Discovery
|
April 1, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
Marina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Cancer Discovery
|
February 6, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes
Marina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
BJU International
|
October 1, 2021
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer
Dimitrios Makrakis, Rafee Talukder, Leonidas N Diamantopoulos, et al.
Page
of 94